INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
AB

Alves Sandra Isabelle Barros

SVP, Finance and CAOCIK 0002065621

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AB
Alves Sandra Isabelle BarrosSVP, Finance and CAO
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
31.6K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Repare Therapeutics Inc.SVP, Finance and CAO · Jan 28, 2026
9
AB
Alves Sandra Isabelle BarrosSVP, Finance and CAO
RPTXRepare Therapeutics Inc.
Disposition to issuer
D
—
26.0K sh
Jan 28, 2026
Jan 28, 2026
traded Jan 28, 2026
+0d
SEC FORM 4

Evidence

9
AB
Alves Sandra Isabelle BarrosSVP, Finance and CAO
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
24.5K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC FORM 4

Evidence